Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 401–500 of 1,001
Chen, C., Lin, C., Wan, S.-W., Wei, L.-S., Chen, M.-C., Yeh, T., Liu, H., Anderson, R., & Lin, Y.-S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201976 · Cited by 49
Williams, C. R., Mincham, G., Ritchie, S. A., Viennet, E., & Harley, D. (2014) · Parasites & Vectors · doi:10.1186/1756-3305-7-447 · Cited by 48
“Approximately 50 million DENV infections occur annually, with a disease burden of around 1300 disability-adjusted life years [1].”
Backgroundda Costa, V. G., Marques-Silva, A. C., & Moreli, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094655 · Cited by 58
“Therefore, dengue poses a major threat to the public health systems of many countries, considering the occurrence of millions of cases and thousands of deaths annually [3].”
BackgroundMagnetic paper – based ELISA for IgM-dengue detection
Ortega, G. A., Rodriguez, S. P., & Reguera, E. (2017) · RSC Advances · doi:10.1039/c6ra25992h · Cited by 48
Monoclonal Antibodies against Zika Virus: Therapeutics and Their Implications for Vaccine Design
Wang, Q., Yan, J., & Gao, G. F. (2017) · Journal of Virology · doi:10.1128/jvi.01049-17 · Cited by 49
“Many reports indicate that the primary infection with DENV generates an antibody response that protects against homologous serotypes, but it might cause the ADE effect during subsequent heterologous infections and exacerbate disease (7, 25, 26).”
BackgroundCheung, K. T., Sze, D., Chan, K. H., & Leung, P. H. M. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.044 · Cited by 54
Curcumin Allosterically Inhibits the Dengue NS2B-NS3 Protease by Disrupting Its Active Conformation
Lim, L., Dang, M., Roy, A., Kang, J., & Song, J. (2020) · ACS Omega · doi:10.1021/acsomega.0c00039 · Cited by 48
Sculpting humoral immunity through dengue vaccination to enhance protective immunity
Crill, W. D., Hughes, H. R., Trainor, N. B., Davis, B. S., Whitney, M. T., & Chang, G. J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00334 · Cited by 48
Halder, S. K., Ahmad, I., Shathi, J. F., Mim, M. M., Hassan, M. R., Jewel, M. J. I., Dey, P., Islam, M. S., Patel, H., Morshed, M. R., et al. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00582-1 · Cited by 50
“When the infection remains unaddressed or overlooked, it can develop from silent or benign to devastating dengue shock syndrome [2].”
Secondary structure and membrane topology of dengue virus NS4B N-terminal 125 amino acids
Li, Y., Kim, Y., Zou, J., Wang, Q.-Y., Gayen, S., Wong, Y. L., Lee, L. T., Xie, X., Huang, Q., Lescar, J., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.09.016 · Cited by 47
“It was estimated that DENV infected 50 to 100 million people in tropical and subtropical regions all over the world [2].”
Quintero-Herrera, L. L., Ramírez-Jaramillo, V., Bernal-Gutiérrez, S., Cárdenas-Giraldo, E. V., Guerrero-Matituy, E. A., Molina-Delgado, A. H., Montoya-Arias, C. P., Rico-Gallego, J. A., Giraldo, A. C. H., Botero, S., et al. (2015) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2014.11.005 · Cited by 47
“In many countries of South East Asia and Latin America, it represents a public health threat that has been considerably affected by climate change and variability [2,3].”
BackgroundMacedo, G. A., Gonin, M. L. C., Pone, S. M., Cruz, O. G., Nobre, F. F., & Brasil, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096314 · Cited by 51
“Dengue is the most widely distributed viral hemorrhagic fever in the tropical world, annually infecting approximately 100 million people in Southeast Asia, the Pacific region, and the Americas and often causing epidemics in urban and peri-urban areas [1].”
BackgroundCLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis
Huang, Y.-L., Chen, S.-T., Liu, R.-S., Chen, Y., Lin, C.-Y., Huang, C., Shu, P., Liao, C., & Hsieh, S.-L. E. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1409-0 · Cited by 47
Cardiac Manifestation in Dengue Fever.
Arora, M., & Patil, R. S. (2016) · PubMed · Cited by 47
Atique, S., Chan, T., Chen, C.-C., Hsu, C., Iqtidar, S., Louis, V. R., Syed-Abdul, S., & Chuang, T. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.12.003 · Cited by 47
A serologic study of dengue in northwest Ethiopia: Suggesting preventive and control measures
Ferede, G., Tiruneh, M., Abate, E., Wondimeneh, Y., Damtie, D., Gadisa, E., Howe, R., Aseffa, A., & Tessema, B. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006430 · Cited by 47
A prospective matched study on symptomatic dengue in pregnancy
Basurko, C., Everhard, S., Matheus, S., Restrepo, M., Hilderal, H., Lambert, V., Boukhari, R., Duvernois, J.-P., Favre, A., Valmy, L., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202005 · Cited by 47
Self-powered mobile sterilization and infection control system
Luo, J., Han, K., Wu, X., Cai, H., Jiang, T., Zhou, H., & Wang, Z. L. (2021) · Nano Energy · doi:10.1016/j.nanoen.2021.106313 · Cited by 49
Lima, A. B., Behnam, M. A. M., Sherif, Y. E., Nitsche, C., Vechi, S. M., & Klein, C. D. P. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.07.012 · Cited by 47
Lateral flow immunoassay (LFIA) for dengue diagnosis: Recent progress and prospect
Ma, Z., Guo, J., Jiang, L., & Zhao, S. (2023) · Talanta · doi:10.1016/j.talanta.2023.125268 · Cited by 46
Assessment of the Health Impacts of Climate Change in Kiribati
McIver, L. J., Woodward, A. J., Davies, S., Tibwe, T., & Iddings, S. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110505224 · Cited by 53
“, implementation of a syndromic surveillance approach) and mosquito control programs have reduced the frequency and intensity of dengue fever outbreaks in other developing countries [42].”
BackgroundEpidemiology of dengue infections in Kassala, Eastern Sudan
Abdallah, T. M., Ali, A. A. A., Karsany, M. S., & Adam, I. (2012) · Journal of Medical Virology · doi:10.1002/jmv.23218 · Cited by 46
“Nevertheless, IgM antibodies can cross-react with other flaviviruses, which can make the interpretation of the serology difficult [Chen and Wilson, 2010; Gubler, 2010; Guzman et al., 2010].”
BackgroundErra, E. O., Korhonen, E. M., Voutilainen, L., Huhtamo, E., Vapalahti, O., & Kantele, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065900 · Cited by 46
“Epidemiologic studies have identified several risk factors for severe disease, including previous exposure to heterologous DENV serotype, infection with certain viral strains and serotypes, young age, female sex, and certain gene variants of the host [8–12].”
BackgroundSurfactant-Modified Nanoclay Exhibits an Antiviral Activity with High Potency and Broad Spectrum
Liang, J., Wei, J.-C., Lee, Y.-L., Hsu, S., Lin, J., & Lin, Y. (2014) · Journal of Virology · doi:10.1128/jvi.03256-13 · Cited by 46
Cellulose‐Based Diagnostic Devices for Diagnosing Serotype‐2 Dengue Fever in Human Serum
Wang, H., Tsai, C., Chen, K., Tang, C., Leou, J., Li, P., Tang, Y., Hsieh, H., Wu, H., & Cheng, C. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300150 · Cited by 46
Manakkadan, A., Mathew, A. J., Jayakumar, B., Issac, A., Nair, S., Abraham, R., Anupriya, M. G., & Sreekumar, E. (2012) · Virus Genes · doi:10.1007/s11262-012-0756-3 · Cited by 46
Gupta, G., Lim, L., & Song, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134823 · Cited by 48
“The disease is caused by Dengue virus (DENV) belonging to the Flaviviridae family, which also includes several other human pathogens such as the West Nile virus, Japanese encephalitis virus, and yellow fever virus [1] [2] [3] [4] .”
Backgroundda Moura, A. J. F., Santos, M. A. V. D. M., de Oliveira, C. M. F., Guedes, D. R. D., de Carvalho-Leandro, D., Brito, M. D. S. D. C., Rocha, H. D. R., Gómez, L. F., & Ayres, C. F. J. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-0706-8 · Cited by 45
“(DENV), which is transmitted to humans by mosquitoes of the genus Aedes, principally Aedes aegypti and Aedes albopictus [3].”
BackgroundKnowledge, attitudes and practices regarding dengue fever in a suburban community in Sri Lanka
Gunasekara, T., Velathanthiri, V., Weerasekara, M. M., Fernando, S., Peelawattage, M. K., Guruge, D., & Fernando, S. (2012) · Galle Medical Journal · doi:10.4038/gmj.v17i1.4355 · Cited by 45
Chuang, Y., Wang, S., Lin, Y.-S., Chen, H., & Yeh, T. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-42 · Cited by 45
“Based on the antigenic differences of the E protein, DENV can be subgrouped into four different serotypes: DENV 1, 2, 3, and 4 [1-3].”
BackgroundWu, D.-W., Mao, F., Ye, Y., Li, J., Chuan-Lian, X., Luo, X., Chen, J., & Shen, X. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.56 · Cited by 45
Fight against dengue in India: progresses and challenges
Gupta, B., & Reddy, B. P. N. (2013) · Parasitology Research · doi:10.1007/s00436-013-3342-2 · Cited by 48
Autochthonous Dengue Outbreak, Paris Region, France, September–October 2023
Zatta, M., Brichler, S., Vindrios, W., Melica, G., & Gallien, S. (2023) · Emerging infectious diseases · doi:10.3201/eid2912.231472 · Cited by 44
“In addition, priming with 1 DENV serotype can increase the risk for severe dengue upon future infection with a heterologous virus ( 8 , 9 ).”
BackgroundAbbasi, E., & Moemenbellah‐Fard, M. D. (2025) · Global Epidemiology · doi:10.1016/j.gloepi.2025.100202 · Cited by 49
“Pakistan, Yemen, Saudi Arabia, Madagascar, and Sudan are among the countries where dengue fever is reported as endemic [74].”
Delivery of intrahemocoelic peptides for insect pest management
Bonning, B. C., & Chougule, N. P. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.08.001 · Cited by 50
de Carvalho, C. X., Gibson, G., Brasil, P., Ferreira, R. A. X., Santos, R. D. S., Cruz, O. G., de Oliveira, S. A., Carvalho, M. S., Pacheco, A. G., Kubelka, C. F., et al. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.08.017 · Cited by 44
One-step real-time RT-PCR assays for serotyping dengue virus in clinical samples
Alm, E., Lindegren, G., Falk, K. I., & Lagerqvist, N. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1226-z · Cited by 45
“In the last decades, the global distribution of dengue virus (DENV) has expanded to include more geographic areas and all four serotypes (DENV1-4) are now present in Asia, Africa, and the Americas [3].”
Amaya-Larios, I. Y., Martínez-Vega, R. A., Mayer, S. V., Galeana-Hernández, M., Comas‐García, A., Sepúlveda-Salinas, K. J., Falcón‐Lezama, J. A., Vasilakis, N., & Ramos‐Castañeda, J. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0145 · Cited by 44
Li, J., Gao, N., Fan, D., Chen, H., Sheng, Z., Fu, S., Liang, G., & An, J. (2016) · Scientific Reports · doi:10.1038/srep19953 · Cited by 44
Kittayapong, P., Olanratmanee, P., Maskhao, P., Byass, P., Logan, J., Tozan, Y., Louis, V., Gubler, D. J., & Wilder-Smith, A. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005197 · Cited by 44
“Children carry a significant burden of morbidity and mortality for dengue with a higher rate of more severe disease than adults [12].”
BackgroundSelf-citationCarabalí, M., Lim, J. K., Velez, D. C., Trujillo, A. I., Egurrola, J., Lee, K. S., Kaufman, J. S., DaSilva, L. J., Vélez, I. D., & Osorio, J. E. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.02.016 · Cited by 44
Takagi, Y., Matsui, K., Nobori, H., Maeda, H., Sato, A., Kurosu, T., Orba, Y., Sawa, H., Hattori, K., Higashino, K., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.027 · Cited by 44
da Rocha, B. A. M., Guilarde, A. O., Argolo, A. F. L. T., Tassara, M. P., da Silveira, L. A., Junqueira, I. C., Turchi, M. D., Féres, V. C. D. R., & Martelli, C. M. T. (2017) · Infectious Diseases of Poverty · doi:10.1186/s40249-017-0328-9 · Cited by 44
Dengue Virus Induces Increased Activity of the Complement Alternative Pathway in Infected Cells
Cabezas, S., Bracho, G. G., Aloia, A. L., Adamson, P. J., Bonder, C. S., Smith, J. R., Gordon, D., & Carr, J. M. (2018) · Journal of Virology · doi:10.1128/jvi.00633-18 · Cited by 44
“Dengue virus (DENV) is currently considered the most important mosquito-borne viral infection of humans worldwide, causing between 50 million and 390 million estimated infections per year in over 100 countries (1, 2).”
BackgroundKDEL Receptors Assist Dengue Virus Exit from the Endoplasmic Reticulum
Li, M. Y., Grandadam, M., Kwok, K., Lagache, T., Siu, Y. L., Zhang, J. S., Sayteng, K., Kudelko, M., Qin, C., Olivo‐Marín, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.021 · Cited by 46
“Despite the global burden of disease, there is no specific treatment and, therefore, a molecular understanding of host-pathogen interactions during the cellular life cycle is needed to guide the development of effective drugs (Guzman et al., 2010).”
BackgroundACREȚEI, M.-V. T., Negreanu–Pîrjol, T., Olariu, L., Negreanu-Pirjol, B.-S., Lepadatu, A.-C., (Cireasa), L. A., & Rosoiu, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020450 · Cited by 48
Auysawasdi, N., Chuntranuluck, S., Phasomkusolsil, S., & Keeratinijakal, V. (2015) · Parasitology Research · doi:10.1007/s00436-015-4725-3 · Cited by 43
Antiviral activity of an N-allyl acridone against dengue virus
Mazzucco, M. B., Talarico, L. B., Vatansever, S., Carro, A. C., Fascio, M. L., D’Accorso, N. B., García, C. C., & Damonte, E. B. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0134-2 · Cited by 43
“The World Health Organization estimates that DENV infects annually 50 million people around the world causing a wide range of clinical disease, from the benign and autolimited dengue fever to the severe forms of dengue hemorrhagic fever and dengue shock syndrome [1,2].”
BackgroundAedes aegypti has spatially structured and seasonally stable populations in Yogyakarta, Indonesia
Rašić, G., Endersby‐Harshman, N. M., Tantowijoyo, W., Goundar, A. A., White, V. L., Yang, Q., Filipović, I., Johnson, P. H., Hoffmann, A. A., & Arguni, E. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-1230-6 · Cited by 47
“A surge in dengue outbreaks is attributed to a combination of factors such as rapid human population growth, migration from rural to urban areas, inadequate basic urban infrastructure and public health measures [3], all of which favor viral transmission by the main vector Aedes aegypti.”
BackgroundHigh Anti–Dengue Virus Activity of theOASGene Family Is Associated With Increased Severity of Dengue
Simon‐Lorière, E., Lin, R.-J., Kalayanarooj, S. M., Chuansumrit, A., Casadémont, I., Lin, S.-Y., Yu, H.-P., Lert-itthiporn, W., Chaiyaratana, W., Tangthawornchaikul, N., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv321 · Cited by 43
“Human genetics [1, 2], secondary infection, and virus genotype have been shown to be associated with disease severity [3].”
BackgroundSelf-citationBryan-Marrugo, O. L., Arellanos-Soto, D., Rojas‐Martínez, A., Barrera-Saldaña, H. A., Ramos‐Jiménez, J., Vidaltamayo, R., & Rivas-Estilla, A. M. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5519 · Cited by 46
“In recent decades, the infection has spread significantly, reaching greater than 50 million cases per year (1).”
Póvoa, T. F., Oliveira, E., Basílio‐de‐Oliveira, C. A., Nuovo, G. J., Chagas, V. L. A., Salomão, N. G., Mota, É. M., & Paes, M. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168973 · Cited by 43
Kuan, M.-M., & Chang, F. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-182 · Cited by 43
“Dengue viremia begins 1 day before the onset of symptoms and lasts for 7–12 days after the onset of symptoms [1,17,20,26].”
BackgroundInfluentialLiu, S., Chen, L., Zeng, Y., Si, L., Guo, X., Zhou, J., Fang, D., Zeng, G., & Jiang, L. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.52 · Cited by 45
A cluster-randomized trial of insecticide-treated curtains for dengue vector control in Thailand
Lenhart, A., Trongtokit, Y., Alexander, N., Apiwathnasorn, C., Satimai, W., Vanlerberghe, V., Van der Stuyft, P., & McCall, P. J. (2013) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0423 · Cited by 42
Omame, A., & Abbas, M. (2023) · Healthcare Analytics · doi:10.1016/j.health.2023.100151 · Cited by 48
Go, Y. Y., Rajapakse, J., Kularatne, S. A. M., Lee, P.-Y. A., Ku, K. B., Nam, S., Chou, P.-H., Tsai, Y., Liu, Y., Chang, H. G., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.00225-16 · Cited by 42
“Furthermore, a number of rapid diagnostic tests targeting NS1 antigen are commercially available; however, false-negative results are still a concern with these assays (17, 18).”
BackgroundTendência da incidência de dengue no Brasil, 2002-2012
Böhm, A. W., Costa, C. D. S., Neves, R. G., Flores, T. R., & Nunes, B. P. (2016) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742016000400006 · Cited by 42
Ramadona, A. L., Tozan, Y., Lazuardi, L., & Rocklöv, J. (2019) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0007298 · Cited by 42
Sasmono, R. T., Kalalo, L. P., Trismiasih, S., Denis, D., Yohan, B., Hayati, R., & Haryanto, S. (2019) · Virology Journal · doi:10.1186/s12985-019-1202-0 · Cited by 48
Mulyatno, K. C., Yamanaka, A., Yotopranoto, S., & Konishi, E. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.274 · Cited by 42
“It is endemic to tropical and subtropical countries, especially in the urban and suburban areas (1).”
BackgroundJoy, T. K., Gutiérrez, E. J., Ernst, K. C., Walker, K. R., Carrière, Y., Torabi, M., & Riehle, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046946 · Cited by 42
“Currently, an estimated 100 million people are infected annually and serious outbreaks are becoming more common [1,2].”
BackgroundAllonso, D., Belgrano, F. S., Calzada, N., Guzmán, M. G., Vázquez, S., & Mohana‐Borges, R. (2012) · Journal of Clinical Virology · doi:10.1016/j.jcv.2012.07.010 · Cited by 42
Thomas, S. J. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24188 · Cited by 41
“Dengue is the world’s most rapidly expanding and important arboviral disease.(2) Millions of people are infected, millions suffer symptomatic disease requiring medical care, and tens of thousands die every year from endemic and epidemic transmission.”
BackgroundGodói, I. P. D., Santos, A. S., Reis, E. A., de Lemos, L. L. P., Ruas, C. M., Campos, J. Á. D. B., Acúrcio, F. D. A., Godman, B., & Guerra, A. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00041 · Cited by 41
“It is estimated that 390 million infections occur annually worldwide (Gubler, 2011; Bhatt et al., 2013), with the number of cases of dengue increasing in frequency and geographic region (Guzman et al., 2010; Brady et al., 2012; Simmons et al., 2012; Bhatt et al., 2013).”
BackgroundFink, A. L., Williams, K. L., Harris, E., Alvine, T., Henderson, T. D., Schiltz, J., Nilles, M. L., & Bradley, D. S. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005721 · Cited by 41
Abachin, É., Convers, S., Falque, S., Esson, R., Mallet, L., & Nougarede, N. (2018) · Biologicals · doi:10.1016/j.biologicals.2018.01.001 · Cited by 46
Dengue fever complicated with Guillain-Barré syndrome: a case report and review of the literature
Dalugama, C., Shelton, J., Ekanayake, M., & Gawarammana, I. (2018) · Journal of Medical Case Reports · doi:10.1186/s13256-018-1626-y · Cited by 41
Atypical lymphocyte count correlates with the severity of dengue infection
Choong, C. S. H., Abeysuriya, V., Mel, S. D., Thilakawardana, B. U., de Mel, P., de Mel, C., Chandrasena, L. G., Seneviratne, S. L., Yip, C. Y. C., & Yap, E. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215061 · Cited by 41
Jung, E., Nam, S., Oh, H., Jun, S., Ro, H., Kim, B., Kim, M., & Go, Y. Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-45095-1 · Cited by 41
Song, C., Zhang, J., Liu, Y., Guo, X., Guo, Y., Jiang, X., & Wang, L. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128970 · Cited by 44
Riboflavin and ultraviolet light: impact on dengue virus infectivity
Faddy, H. M., Fryk, J. J., Watterson, D., Young, P. R., Modhiran, N., Muller, D. A., Keil, S. D., Goodrich, R. P., & Marks, D. C. (2016) · Vox Sanguinis · doi:10.1111/vox.12414 · Cited by 41
Update: The diagnosis and management of dengue virus infection in North America
Wright, W. F., & Pritt, B. S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.03.021 · Cited by 40
“During a secondary or tertiary infection, IgM titers rise much slower than IgG titers andmay result in false-negative tests (De Paula and Fonseca, 2004; Guzman et al., 2010; Halstead, 2007; Innis et al., 1989; Shu and Huange, 2004).”
BackgroundMethodInfluentialMachado, A. A. V., Estevan, A. O., Junior, A. F. D. S., Brabes, K. C. D. S., Croda, J., & Negrão, F. J. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003104 · Cited by 48
“Sequential heterotypic infections are also common in dengue-endemic areas [8].”
BackgroundXu, H., Colby-Germinario, S. P., Hassounah, S. A., Quashie, P. K., Han, Y.-S., Oliveira, M., Stranix, B. R., & Wainberg, M. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02203-15 · Cited by 40
Louis, V. R., Montenegro-Quiñonez, C. A., Kusumawathie, P. H. D., Palihawadana, P., Janaki, S., Tozan, Y., Wijemuni, R., Wilder‐Smith, A., & Tissera, H. A. (2016) · Pathogens and Global Health · doi:10.1080/20477724.2016.1175158 · Cited by 47
Phommanivong, V., Kanda, S., Shimono, T., Lamaningao, P., Darcy, A. W., Mishima, N., Phaytanavanh, B., & Nishiyama, T. (2016) · Tropical Medicine and Health · doi:10.1186/s41182-016-0020-y · Cited by 40
“DENV is endemic in Southeast Asia, the Pacific, and the Americas [2].”
Backgrounddo Nascimento, L. B., Siqueira, C. M., Coelho, G. E., & Siqueira, J. B. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30169-x · Cited by 40
Accuracy of the SD BIOLINE Dengue Duo for rapid point-of-care diagnosis of dengue
Kikuti, M., Cruz, J. S., Rodrigues, M. M. D. S., Tavares, A. S., Paploski, I. A. D., Silva, M. M. O., Santana, P. M., Tauro, L. B., Silva, G. A. O. F., Campos, G. S., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213301 · Cited by 46
“In addition, the lower IgM production in secondary dengue infections would reduce the sensitivity of the IgM component of the test [29].”
BackgroundDesign, synthesis and discovery of andrographolide derivatives against Zika virus infection
Li, F., Lee, E. M., Sun, X., Wang, D., Tang, H., & Zhou, G. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111925 · Cited by 40
“However, the international air travel is increased in the contemporary world by which a virus could be imported from one country into other countries in the tropical and subtropical regions [18].”
BackgroundDengue NS1 detection in pediatric serum using microfluidic paper-based analytical devices
Prabowo, M. H., Chatchen, S., Rijiravanich, P., Limkittikul, K., & Surareungchai, W. (2020) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-020-02527-6 · Cited by 40
Namekar, M., Ellis, E. M., O'Connell, M., Elm, J., Gurary, A., Park, S. Y., Imrie, A. A., & Nerurkar, V. R. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00351-13 · Cited by 40
“Dengue virus (DENV) a mosquito-borne flavivirus, is a significant human pathogen of global importance (1).”
BackgroundAguiar, M., Kooi, B. W., Rocha, F., Ghaffari, P., & Stollenwerk, N. (2012) · Ecological Complexity · doi:10.1016/j.ecocom.2012.09.001 · Cited by 40
Muñoz, M. D. L., Limón-Camacho, G., Tovar, R., Díaz-Badillo, Á., Mendoza‐Hernández, G., & Black, W. C. (2013) · BioMed Research International · doi:10.1155/2013/875958 · Cited by 40
“Dengue virus is transmitted to humans in America mainly by the mosquito vectors Aedes aegypti [7] infecting primary human cells such as peripheral blood leukocytes, blood monocytes/macrophages, dendritic cells, and B lymphocytes [7].”
BackgroundGu, X., Ross, P. A., Rodriguez‐Andres, J., Robinson, K. L., Yang, Q., Lau, M., & Hoffmann, A. A. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.15966 · Cited by 42
“Aedes aegypti mosquitoes transmit some of the most important arboviral diseases such as dengue, which remain a major cause of morbidity and mortality across tropical regions (Kyle and Harris, 2008; Guzman et al., 2010).”
BackgroundBhakat, S., Delang, L., Kaptein, S. J. F., Neyts, J. H., Leyssen, P., & Jayaprakash, V. (2015) · RSC Advances · doi:10.1039/c5ra14469h · Cited by 44
Lindow, J. C., Borochoff-Porte, N., Durbin, A. P., Whitehead, S. S., Fimlaid, K. A., Bunn, J. Y., & Kirkpatrick, B. D. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001742 · Cited by 39
“100 countries are currently at risk for acquiring DENV infection [1,2].”
BackgroundSasmono, R. T., Aryati, A., Wardhani, P., Yohan, B., Trimarsanto, H., Fahri, S., Setianingsih, T. Y., & Meutiawati, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103815 · Cited by 39
“The genome consists of single-stranded positive-sense RNA which encodes three structural (C, prM/M, E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) [1].”
BackgroundInfluentialDevelopment of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2
Li, P., Liao, M., Cheng, P.-C., Liang, J., Liu, I.-J., Chiu, C., Lin, Y., Chang, G. J., & Wu, H. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001636 · Cited by 39
“5 billion people are at risk of dengue infection globally [1,2].”
BackgroundRascón, A. A., Gearin, J., Isoe, J., & Miesfeld, R. L. (2011) · BMC Biochemistry · doi:10.1186/1471-2091-12-43 · Cited by 39
“Because of the resurgence in Dengue fever in tropical and subtropical regions of the world [3,4], and the global persistence of malarial parasite infections [5], it is critical to understand biochemical processes required for blood meal metabolism as a means to develop effective vector control strategies.”
BackgroundLinares, N. C., Ortega-Dávila, E., López-González, M., García‐Machorro, J., García‐Cordero, J., Steinman, R. M., Cedillo‐Barrón, L., & Gómez-Lim, M. Á. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.03.009 · Cited by 39
“About 50–100 million of nfected individuals and 20,000 deaths are reported annually [1,2].”
BackgroundReticulate Evolution: Symbiogenesis, Lateral Gene Transfer, Hybridization and Infectious Heredity
Gontier, N. (2015) · Interdisciplinary evolution research · doi:10.1007/978-3-319-16345-1 · Cited by 46
“It comprises four related serotypes that are moderately close (uncreatively named DENV-1 through 4), sharing a little over 65 % of genetic sequence similarity (Guzman et al. 2010).”
BackgroundDengue Virus Immunopathogenesis: Lessons Applicable to the Emergence of Zika Virus
Olagnier, D. P., Amatore, D., Castiello, L., Ferrari, M., Palermo, E., Diamond, M., Palamara, A. T., & Hiscott, J. B. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.04.024 · Cited by 42
Serum Galectin-9 and Galectin-3-Binding Protein in Acute Dengue Virus Infection
Liu, K., Liu, Y., Chen, Y., Lin, C., Huang, C., Yen, M., & Kuo, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060832 · Cited by 43
“Dengue fever is a mosquito-borne viral disease and is caused by dengue virus (type I–IV) [1].”
BackgroundSerum Metabolomics Investigation of Humanized Mouse Model of Dengue Virus Infection
Liang, C., Hou, J., Fang, J., Lee, Y. H., Costa, V. V., Wong, L. H., Chen, Q., Ooi, E. E., Tannenbaum, S. R., Chen, J., et al. (2017) · Journal of Virology · doi:10.1128/jvi.00386-17 · Cited by 39
“In the absence of an effective antiviral drug and with the rapid spread of DENV, which is now circulating in Asia, Africa, and the Americas, dengue has become a major public health threat worldwide (3).”
BackgroundWei, S., Xue, L., & Xie, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-13163-z · Cited by 44
The role of lipids in the inception, maintenance and complications of dengue virus infection
Melo, C. F. O. R., Delafiori, J., Dabaja, M. Z., de Oliveira, D. N., Guerreiro, T. M., Colombo, T. E., Nogueira, M. L., Proença‐Módena, J. L., & Catharino, R. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-30385-x · Cited by 39
Zandi, K., Bassit, L., Amblard, F., Cox, B. D., Hassandarvish, P., Moghaddam, E., Yueh, A., Rodrigues, G. O. L., Passos, I. B. S., Costa, V. V., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00397-19 · Cited by 39
Incidence dynamics and investigation of key interventions in a dengue outbreak in Ningbo City, China
Yi, B., Chen, Y., Ma, X., Rui, J., Cui, J., Wang, H., Li, J., Chan, S.-F., Wang, R., Ding, K., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007659 · Cited by 47
Origin and Spread of the Dengue Virus Type 1, Genotype V in Senegal, 2015–2019
Dieng, I., Cunha, M. D. P., Diagne, M. M., Sembène, P. M., Zanotto, P. M. D. A., Faye, O., Faye, O., & Sall, A. A. (2021) · Viruses · doi:10.3390/v13010057 · Cited by 39
“DENV is an enveloped, positive-sense, single-stranded RNA virus that belongs to the genus Flavivirus, family Flaviviridae [4,5].”
Background
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.